MCG Discovery Study in Emergency Departments

Launched by SB TECHNOLOGY, INC. · Oct 18, 2023

Keywords

ClinConnect Summary

The MCG Discovery Study is a research trial taking place in Emergency Departments (ED) that aims to explore the use of a special mobile device called MCG to gather important health information from patients with potential heart problems, specifically Acute Coronary Syndrome (ACS). This study will help researchers understand if this device can effectively collect and interpret data while patients are being treated in the ED. The trial is currently looking for participants aged 65 to 74 who show symptoms of ACS and can give their consent to join the study.

To be eligible for this trial, patients must be experiencing symptoms that suggest a heart issue but cannot have certain conditions like ST-Elevation Myocardial Infarction (STEMI) or Atrial Fibrillation. If you join this study, you will likely undergo some tests with the MCG device during your visit to the ED. It’s a great opportunity to contribute to research that could improve how heart conditions are diagnosed and treated in emergency situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
• • Can provide written consent
• Exclusion Criteria:
• • Presents to ED with ST-Elevation Myocardial Infarction (STEMI)
• • Presents to ED with Atrial Fibrillation
• • Clear non-ischemic cause for symptoms (i.e. trauma)
• • Active thoracic metal implants